0001640455-22-000035.txt : 20220317
0001640455-22-000035.hdr.sgml : 20220317
20220317205055
ACCESSION NUMBER: 0001640455-22-000035
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220317
DATE AS OF CHANGE: 20220317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole Hugh M
CENTRAL INDEX KEY: 0001604646
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 22750799
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
wf-form4a_164756463871771.xml
FORM 4/A
X0306
4/A
2022-02-01
2022-02-03
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001604646
Cole Hugh M
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Business Officer
Stock Option (Right to Buy)
7.56
2022-02-01
4
A
0
85000
0
A
2032-02-01
Common Stock
85000.0
85000
D
The Stock Option will vest (i) as to 55,000 shares of the Stock Option, quarterly in 16 equal installments following January 1, 2022 and (ii) as to 30,000 shares of the Stock Option, on January 1, 2023.
This Form 4/A amends the Form 4 filed on February 3, 2022 to correct the vesting schedule of the Stock Option granted to the Reporting Person.
/s/ Caroline Gammill, Attorney-in-fact
2022-03-17